Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI

NCT00242112 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00242112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00242112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2005
Completion date
February 29, 2008
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer